Literature DB >> 8041414

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.

D L Fischman1, M B Leon, D S Baim, R A Schatz, M P Savage, I Penn, K Detre, L Veltri, D Ricci, M Nobuyoshi.   

Abstract

BACKGROUND: Coronary-stent placement is a new technique in which a balloon-expandable, stainless-steel, slotted tube is implanted at the site of a coronary stenosis. The purpose of this study was to compare the effects of stent placement and standard balloon angioplasty on angiographically detected restenosis and clinical outcomes.
METHODS: We randomly assigned 410 patients with symptomatic coronary disease to elective placement of a Palmaz-Schatz stent or to standard balloon angioplasty. Coronary angiography was performed at base line, immediately after the procedure, and six months later.
RESULTS: The patients who underwent stenting had a higher rate of procedural success than those who underwent standard balloon angioplasty (96.1 percent vs. 89.6 percent, P = 0.011), a larger immediate increase in the diameter of the lumen (1.72 +/- 0.46 vs. 1.23 +/- 0.48 mm, P < 0.001), and a larger luminal diameter immediately after the procedure (2.49 +/- 0.43 vs. 1.99 +/- 0.47 mm, P < 0.001). At six months, the patients with stented lesions continued to have a larger luminal diameter (1.74 +/- 0.60 vs. 1.56 +/- 0.65 mm, P = 0.007) and a lower rate of restenosis (31.6 percent vs. 42.1 percent, P = 0.046) than those treated with balloon angioplasty. There were no coronary events (death; myocardial infarction; coronary-artery bypass surgery; vessel closure, including stent thrombosis; or repeated angioplasty) in 80.5 percent of the patients in the stent group and 76.2 percent of those in the angioplasty group (P = 0.16). Revascularization of the original target lesion because of recurrent myocardial ischemia was performed less frequently in the stent group than in the angioplasty group (10.2 percent vs. 15.4 percent, P = 0.06).
CONCLUSIONS: In selected patients, placement of an intracoronary stent, as compared with balloon angioplasty, results in an improved rate of procedural success, a lower rate of angiographically detected restenosis, a similar rate of clinical events after six months, and a less frequent need for revascularization of the original coronary lesion.

Entities:  

Mesh:

Year:  1994        PMID: 8041414     DOI: 10.1056/NEJM199408253310802

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  385 in total

Review 1.  Antithrombotic therapy in cardiac stent patients.

Authors:  C R Cannan
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

Review 2.  Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.

Authors:  S R Steinhubl; E J Topol
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

3.  [Hemostatic closure of arterial puncture site using Angio-Seal after diagnostic heart catheterization or coronary intervention].

Authors:  H Eggebrecht; M Haude; D Baumgart; O Oldenburg; J Herrmann; C Bruch; P Hunold; C Neurohr; C von Birgelen; D Welge; M A Katz; R Erbel
Journal:  Herz       Date:  1999-12       Impact factor: 1.443

4.  The Duett closure device: concept and experimental results.

Authors:  G Gershony; T Jensen
Journal:  Herz       Date:  1999-12       Impact factor: 1.443

Review 5.  Intervention in coronary artery disease.

Authors:  S Windecker; B Meier
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

6.  Intravascular radiotherapy: restenosis and more?

Authors:  P Wexberg; M Gottsauner-Wolf
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

Review 7.  Revascularization strategies in patients with diabetes: evolving concepts.

Authors:  J J Brennan; H S Cabin
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

8.  Adjunctive Pharmacologic Treatment: Focus on the Development of Low Molecular Weight Heparins.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 9.  Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors.

Authors:  F H Jafary; C D Kimmelstiel
Journal:  J Thromb Thrombolysis       Date:  2000-02       Impact factor: 2.300

Review 10.  Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.

Authors:  F H Jafary; C D Kimmelstiel
Journal:  J Thromb Thrombolysis       Date:  2000-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.